Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
BridgeBio Oncology Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | Buy | n/a (No price was disclosed in the filing) | conv 58First in 12mo | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Buy | $26.4M | conv 38Cluster | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Buy | $28.6M | conv 48Cluster | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Buy | $504.9K | conv 25Cluster | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Buy | $506.2K | conv 24Cluster | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Buy | $37.2K | conv 24Cluster | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Buy | $69.8K | conv 24Cluster | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Buy | $519.9K | conv 24ClusterUnusual size | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Sell | $37.2K | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | Sell | $504.9K | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | Sell | $506.2K | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | Sell | $519.9K | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | Sell | $69.8K | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | Buy | $27.1M | conv 44Cluster | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Buy | $15.5M | conv 35Cluster | SEC | |
Eidos Therapeutics, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | Other | $3.6M | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | Buy | $17M | conv 43ClusterFirst in 12mo | SEC | |
Eidos Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Eidos Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |